Physician

Robert Jeffrey Lee, M.D.

According to 2025 Medicare claims, Robert Lee, M.D. (NPI: 1548219991) practices radiation oncology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is UTAH CANCER SPECIALISTS PC (NPI: 1619925369; TIN: 870519691) and primary practice location at 84106-1494. Lee is affiliated with the Castell Accountable Care, LLC (ACO ID: D0136), participating under the REACH model.

Lee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 246 traditional Medicare patients, billed 7,570 HCPCS/CPT codes, and received $1,382,866 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 301 prescription claims across 102 beneficiaries totaling $8,821 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 8 records totaling $2,232. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $362,843 to $1,382,866. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $8,490 and ending at $8,821. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	171	3,621	$362,843
2016	190	2,784	$271,626
2017	175	2,582	$279,957
2018	167	3,538	$342,353
2019	212	2,380	$279,874
2020	216	3,179	$338,421
2021	211	3,486	$358,085
2022	242	2,106	$223,080
2023	207	2,958	$358,358
2024	246	7,570	$1,382,866

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	69	280	$8,490
2016	72	246	$7,176
2017	90	292	$6,891
2018	110	401	$6,740
2019	109	346	$6,420
2020	116	468	$11,534
2021	116	428	$8,716
2022	114	281	$8,480
2023	93	274	$5,463
2024	102	301	$8,821

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	52	52	$137
77263	Complex radiation therapy planning	53	55	$124
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	91	110	$45
77014	Ct guidance for insertion of radiation therapy fields	50	182	$33
77300	Calculation of radiation therapy dose	51	153	$32

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	136	7,396	$2,164
Oxybutynin Chloride Er	Oxybutynin Chloride	45	2,030	$490
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	142	$149
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	53	$103

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$132	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$2,100	INTERMOUNTAIN MEDICAL CENTER
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert Jeffrey Lee, M.D.?

Tedicare shows public-source Medicare data for Robert Jeffrey Lee, M.D. (NPI 1548219991), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Jeffrey Lee, M.D. have ACO affiliation data?

Robert Jeffrey Lee, M.D. is shown with ACO affiliation data for Castell Accountable Care, LLC (REACH, ACO ID D0136).

What billing organization is linked to Robert Jeffrey Lee, M.D.?

Robert Jeffrey Lee, M.D. is linked to UTAH CANCER SPECIALISTS PC (billing NPI 1619925369) in the available physician profile data.

Does Robert Jeffrey Lee, M.D. have Open Payments data?

Robert Jeffrey Lee, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.